Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer

Investigational Site Number : 1580005, Taipei

Investigational Site Number : 1580004, Taipei

Investigational Site Number : 1580003, Tainan City

Investigational Site Number : 0320007, Capital Federal

Investigational Site Number : 0320005, Rosario

Investigational Site Number : 0560001, Leuven

Investigational Site Number : 0360003, South Brisbane

Investigational Site Number : 0360002, Woolloongabba

Investigational Site Number : 0320002, Salta

Investigational Site Number : 0560003, Namur

Investigational Site Number : 0320004, La Rioja

Investigational Site Number : 0360001, Nedlands

Investigational Site Number : 1580001, Taipei

Investigational Site Number : 3800001, Candiolo

Investigational Site Number : 2500007, Marseille

Investigational Site Number : 2030004, Prague

Investigational Site Number : 3800002, Milan

Investigational Site Number : 7920002, Edirne

Investigational Site Number : 7240008, Málaga

Investigational Site Number : 7920003, Istanbul

Alabama Oncology Site Number : 8400008, Birmingham

Investigational Site Number : 1580002, Taichung

Investigational Site Number : 3000002, Larissa

Gabrail Cancer Center Site Number : 8400006, Canton

Investigational Site Number : 2500008, Angers

Investigational Site Number : 3760001, Petah Tikva

Investigational Site Number : 8040001, Kryvyi Rih

Investigational Site Number : 3760004, Tel Litwinsky

University of Wisconsin Site Number : 8400016, Madison

Investigational Site Number : 3000004, Thessaloniki

Investigational Site Number : 3800003, Prato

Saint Luke's Hospital Site Number : 8400032, Kansas City

Investigational Site Number : 3760003, Tel Aviv

Investigational Site Number : 4840002, Monterrey

Investigational Site Number : 8040004, Odesa

Investigational Site Number : 2030002, Brno

The University of Kansas Clinical Research Center Site Number : 8400027, Fairway

Hematology Oncology Clinic Site Number : 8400020, Baton Rouge

Investigational Site Number : 3000001, Heraklion

Investigational Site Number : 2500005, Paris

The Center For Cancer And Blood Disorders Site Number : 8400022, Fort Worth

Investigational Site Number : 8040005, Uzhhorod

UCLA Hematology Oncology Parkside Site Number : 8400024, Santa Monica

Investigational Site Number : 3760002, Jerusalem

Investigational Site Number : 4840006, Veracruz

Comprehensive Blood and Cancer Center Site Number : 8400018, Bakersfield

Investigational Site Number : 2500006, Créteil

Investigational Site Number : 2500001, Villejuif

Northwest Medical Specialties Site Number : 8400038, Tacoma

Investigational Site Number : 1560001, Beijing

Investigational Site Number : 6430003, Moscow

Investigational Site Number : 6430005, Moscow

Investigational Site Number : 1560015, Changchun

Investigational Site Number : 1560005, Harbin

Investigational Site Number : 6430002, Saint Petersburg

Investigational Site Number : 1560011, Nanjing

Investigational Site Number : 1560010, Hefei

Investigational Site Number : 1560018, Hefei

Investigational Site Number : 1560026, Jinan

Investigational Site Number : 1560008, Linyi

Investigational Site Number : 1560013, Tianjin

Investigational Site Number : 1560023, Hangzhou

Investigational Site Number : 1560002, Hangzhou

Investigational Site Number : 1560024, Chongqing

Investigational Site Number : 1560014, Changsha

Investigational Site Number : 1560016, Wuhan

Investigational Site Number : 1560025, Chengdu

Investigational Site Number : 1560003, Kunming

Investigational Site Number : 1560021, Ürümqi

Hospital de Clinicas de Porto Alegre - HCPA Site Number : 0760001, Porto Alegre

Dana Farber Cancer Institute Site Number : 8400015, Boston

Dartmouth Hitchcock Med Center Site Number : 8400013, Lebanon

Hackensack University Medical Center Site Number : 8400025, Hackensack

University Of Vermont Site Number : 8400026, Burlington

Investigational Site Number : 0320008, CABA

Investigational Site Number : 0320001, Buenos Aires

Investigational Site Number : 0320006, Buenos Aires

Investigational Site Number : 0560002, Charleroi

Hospital Araujo Jorge Site Number : 0760005, Goiânia

Hospital Mae de Deus Site Number : 0760002, Porto Alegre

Hospital de Base Sao Jose do Rio Preto Site Number : 0760003, São José do Rio Preto

Nucleo de Pesquisa Clinica e Ensino da Rede Sao Camilo Site Number : 0760006, São Paulo

Investigational Site Number : 1240004, Calgary

Investigational Site Number : 1240003, London

Investigational Site Number : 1240006, Montreal

Investigational Site Number : 1560031, Xuzhou

Investigational Site Number : 2030003, Nový Jičín

Investigational Site Number : 3920002, Nagoya

Investigational Site Number : 3920001, Kashiwa-shi

Investigational Site Number : 3920009, Ota-shi

Investigational Site Number : 3920006, Yokohama

Investigational Site Number : 3920003, Osaka

Investigational Site Number : 3920005, Kitaadachi-gun

Investigational Site Number : 3920004, Chuo-ku

Investigational Site Number : 3920008, Koto-ku

Investigational Site Number : 4280002, Riga

Investigational Site Number : 4280001, Riga

Investigational Site Number : 4840005, México

Investigational Site Number : 6160003, Poznan

Investigational Site Number : 6160001, Warsaw

Torre Hospital Auxilo Mutuo Site Number : 8400028, Ponce de Leon 735 Hato Rey

Investigational Site Number : 4100001, Seoul

Investigational Site Number : 4100004, Seoul

Investigational Site Number : 4100003, Seoul

Investigational Site Number : 4100002, Seoul

Investigational Site Number : 7240006, Barcelona

Investigational Site Number : 7240001, L'Hospitalet de Llobregat

Investigational Site Number : 7240003, Barcelona

Investigational Site Number : 7920004, Ankara